Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$265K Hold
709
0.02% 240
2024
Q1
$246K Hold
709
0.02% 254
2023
Q4
$325K Hold
709
0.03% 221
2023
Q3
$345K Hold
709
0.03% 206
2023
Q2
$317K Hold
709
0.03% 218
2023
Q1
$344K Hold
709
0.03% 208
2022
Q4
$363K Sell
709
-96
-12% -$50.5K 0.04% 208
2022
Q3
$391K Hold
805
0.04% 191
2022
Q2
$377K Hold
805
0.04% 192
2022
Q1
$350K Sell
805
-13
-2% -$5.44K 0.03% 213
2021
Q4
$379K Buy
818
+18
+2% +$7.96K 0.03% 213
2021
Q3
$311K Hold
800
0.03% 215
2021
Q2
$354 Hold
800
0.03% 209
2021
Q1
$335K Buy
+800
New +$319K 0.03% 206

Other funds holding HUM

HoyleCohen's HUM Position: Q2 2024 in Review

HoyleCohen held its Humana (HUM) position steady in Q2 2024 at 709 shares worth $265K. The position accounts for 0.02% of the portfolio, ranked #240.

HoyleCohen first reported a position in HUM in Q1 2021 and has held it in 14 quarters since. The position peaked at $391K in Q3 2022. 979 funds tracked by Wall St. Rank hold HUM as of Q2 2024.

  • HoyleCohen held 709 shares of Humana worth $265K as of Q2 2024.
  • HoyleCohen left its Humana share count unchanged in Q2 2024.
  • Humana made up 0.02% of HoyleCohen's portfolio in Q2 2024, its #240 holding.
  • HoyleCohen first reported a position in Humana in Q1 2021 and has held it in 14 quarters since.
  • HoyleCohen's Humana position peaked at $391K in Q3 2022.
  • 979 funds tracked by Wall St. Rank held Humana as of Q2 2024.

Based on HoyleCohen's 13F filing for Q2 2024, filed 19 Jul 2024.